Effectiveness Study of Short Course of Magnesium Sulfate for Severe Preeclamsia

• Status: Completed
• Trial end date: 2012-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Magnesium sulfate is the ideal drug for seizures prophilaxis in preeclampsia. The ideal duration of this treatment after delivery is still to be established. The hypothesis is that in stable patients a shorter course of treatment is possible without prejudice to the mother.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
• Treatments: Magnesium Sulfate

Criteria

Inclusion Criteria:

• Pre-eclampsia;

• Puerperium.

Exclusion Criteria:

• Associated maternal diseases;

• Use of illicit drugs or other medications that might interfere with maternal hemodynamics;

• Contraindications to the use of magnesium sulfate: drug hypersensitivity, oliguria with urine output below 25ml/h; anuria (absent urine output), myasthenia gravis.